Theranos ’ AACC Presentation: Not the Reboot We Were Hoping For

Move over, Edison: here comes miniLab. And yet: “Every piece of technology they presented has been known for many years, and exists in other platforms largely in the same configuration, or in some cases in much more compact form in competitor’s platforms.” ~ associate professor in U. Washington’s dept of laboratory medicine. Data has not been independently verified. Holmes did not clarify that the 11 tests she presented would require at least 3-4 pricks if each prick yields only 160-uL amounts. http://www.wsj.com/articles/theranos-founder-elizabeth-holmes-introduces-new-blood-testing-device-1470089582 Theranos Had a Chance to Clear Its Name. Instead, It Tried to Pivot
Source: NAKEDMEDICINE.COM - Category: Consumer Health News Authors: Tags: Business of Medicine Source Type: blogs